Arch Fam Med
Institution: STANFORD Univ Med Center  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 2 No. 4, April 1993 TABLE OF CONTENTS
  •  Online Features
  Original Contributions
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Transdermal Nicotine Patches With Low-Intensity Support to Aid Smoking Cessation in Outpatients in a General Hospital

A Placebo-Controlled Trial

Jonathan Foulds, MAppSci; John Stapleton, MSc; Mary Hayward; Michael A. H. Russell, FRCP; Colin Feyerabend, PhD; Tracey Fleming; John Costello, MD, FRCP

Arch Fam Med. 1993;2(4):417-423.

Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. Jarvis MJ, Russell MAH. Treatment for the cigarette smoker. Int Rev Psychiatry. 1989;1:139-147.
2. Lam W, Sze PC, Sacks HS, Chalmers TC. Meta-analysis of randomised controlled trials of nicotine chewing-gum. Lancet. 1987;2:27-29. PUBMED
3. Campbell IA, Prescott RJ, Tjeder-Burton SM. Smoking cessation in hospital patients given repeated advice plus nicotine or placebo gum. Respir Med. 1991;85:155-157. PUBMED
4. British Thoracic Society. Comparison of four methods of smoking withdrawal in patients with smoking-related diseases. BMJ. 1983;286:595-597. FREE FULL TEXT
5. Hughes JR, Gust SW, Keenan RM, Fenwick JW, Healey ML. Nicotine vs placebo gum in general medical practice. JAMA. 1989;261:1300-1305. FREE FULL TEXT
6. Abelin T, Buehler A, Muller P, Vesanen K, Imhof PR. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet. 1989;1:7-10. PUBMED
7. Abelin T, Ehrsam R, Buhler-Reichert A, et al. Effectiveness of a transdermal nicotine system in smoking cessation studies. Methods Find Exp Clin Pharmacol. 1989;11:205-214. PUBMED
8. Buchkremer G, Bents M, Horstmann K, Opitz K, Tolle R. Combination of behavioral smoking cessation with transdermal nicotine substitution. Addict Behav. 1989;14:229-238. PUBMED
9. Daughton DM, Heatley SA, Prendergast JJ, et al. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy: a randomized, placebo-controlled, double-blind study. Arch Intern Med. 1991;151:749-752. FREE FULL TEXT
10. Hurt RD, Lauger GG, Offord KP, Kottke TE, Dale LC. Nicotine-replacement therapy with use of a transdermal nicotine patch: a randomized double-blind placebocontrolled trial. Mayo Clin Proc. 1990;65:1529-1537. PUBMED
11. Mulligan SC, Masterton JG, Devane JG, Kelly JG. Clinical and pharmacokinetic properties of a transdermal nicotine patch. Clin Pharmacol Ther. 1990;47:331-337. PUBMED
12. Rose J, Levin ED, Behm FM, Adivi C, Schur C. Transdermal nicotine facilitates smoking cessation. Clin Pharmacol Ther. 1990;47:323-330. PUBMED
13. Tonnesen P, Norregaard, J, Simonsen K, Sawe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med. 1991;325:311-315. ABSTRACT
14. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation: six-month results from two multicenter controlled clinical trials. JAMA. 1991;266:3133-3138. FREE FULL TEXT
15. Russell MA, Peto J, Patel UA. The classification of smoking by factorial structure of motives. J R Stat Soc. 1974;137:313-333.